Although the inactivation of VHL gene alone is not sufficient to cause tumors (12, 13), a study of ccRCC patients from Germany suggested that low expression of VHL was identified as a risk factor for worse overall survival (OS) (14). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.